Fero Industries to Acquire Pyro Pharmaceuticals, Inc.'s Enzyme Identification Methodology under Definitive Agreement.

Pyro Methodology Holds the Potential to Attack Antibiotic Resistant Bacteria

CALGARY, Alberta -- Fero Industries, Inc. (OTCBB: FROI) (the "Company") is pleased to announce that it is acquiring Pyro Pharmaceuticals, Inc.'s patented enzyme identification methodology through its pending acquisition of Pyro Pharmaceuticals. As previously announced, Fero has initiated the process of acquiring Pyro Pharmaceuticals, Inc. through an exchange of Pyro's capital stock ...

If you are already a vLex customer, Access Here